In vitro evaluation of chitosan-DNA plasmid complex encoding Jembrana disease virus Env-TM protein as a vaccine candidate

1. Budiarso I.T., Hardjosworo S.: Jembrana disease in Bali cattle. Aust Vet J 1976, 52, 97–97.10.1111/j.1751-0813.1976.tb13867.xSearch in Google Scholar

2. Burkala E.J., Narayani I., Hartaningsih N., Kertayadnya G., Berryman D.I., Wilcox G.E.: Recombinant Jembrana disease virus proteins as antigens for the detection of antibody to bovine lentiviruses. J Virol Methods 1998, 74, 39–46.10.1016/S0166-0934(98)00066-4Search in Google Scholar

3. Chadwick B.J., Desport M., Brownlie J., Wilcox G.E., Dharma D.M.N.: Detection of Jembrana disease virus in spleen, lymph nodes, bone marrow and other tissues by in situ hybridization of paraffin-embedded sections. J Gen Virol 1998, 79, 101–106.10.1099/0022-1317-79-1-101Search in Google Scholar

4. Chen H., Wilcox G., Kertayadnya G., Wood C.: Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats. J Virol 1999, 73, 658–666.10.1128/JVI.73.1.658-666.1999Search in Google Scholar

5. Craigo J.K., Montelaro R.C.: Lessons in AIDS vaccine development learned from studies of equine infectious anemia virus infection and immunity. Viruses 2013, 5, 2963–2976.10.3390/v5122963Search in Google Scholar

6. Ditcham W.G.F.: The development of recombinant vaccines against Jembrana disease, Murdoch University 2007, http://researchrepository.murdoch.edu.au/id/eprint/438.Search in Google Scholar

7. Ditcham W.G.F., Lewis J.R., Dobson R.J., Hartaningsih N., Wilcox G.E., Desport M.: Vaccination reduces the viral load and the risk of transmission of Jembrana disease virus in Bali cattle. Virology 2009, 386, 317–324.10.1016/j.virol.2009.02.008Search in Google Scholar

8. Gregory A.E., Titball R., Williamson D.: Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 2013, 3, doi: 10.3389/fcimb.2013.00013.10.3389/fcimb.2013.00013Search in Google Scholar

9. Haas J., Park E.C., Seed B.: Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 1996, 6, 315–324.10.1016/S0960-9822(02)00482-7Search in Google Scholar

10. Hartaningsih N., Wilcox G.E., Dharma D.M.N., Soetrismo M.: Distribution of Jembrana disease in cattle in Indonesia. Vet Microbiol 1993, 38, 23–29.10.1016/0378-1135(93)90072-FSearch in Google Scholar

11. Hashimoto M., Yang Z., Koya Y., Sato T.: Chitosan. In: Non-viral Gene Therapy: Gene Design and Delivery, edited by Taira K., Kataoka K., Niidome T., Springer-Verlag, Tokyo, Japan, 2005, pp. 63–74.10.1007/4-431-27879-6_6Search in Google Scholar

12. Issel C.J., Horohov D.W., Lea D.F., Adams W.V., Hagius S.D., McManus J.M., Allison A.C., Montelaro R.C.: Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol 1992, 66, 3398–3408.10.1128/jvi.66.6.3398-3408.19922411201316455Search in Google Scholar

13. Kharia A.A., Singhai A.K., Verma R.: Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention. Int J Pharm Pharm Sci 2012, 4, 1557–1562.10.37285/ijpsn.2011.4.4.6Search in Google Scholar

14. Kusumawati A., Hidayat B., Sardjono B., Widada J.S.: Isolation-amplification of env-tm subunit genes of Jembrana disease virus by a single step RT-PCR and its direct cloning in pCR2.1-TOPO plasmid. Buletin Peternakan 2012, 27, 1–7, doi: 10.21059/buletinpeternak.v27i1.1459.10.21059/buletinpeternak.v27i1.1459Search in Google Scholar

15. Leutenegger C.M., Hofmann-Lehmann R., Holznagel E., Cuisinier A.M., Wolfensberger C., Duquesne V., Cronier J., Allenspach K., Aubert A., Ossent P., Lutz, H.: Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins. AIDS Res Hum Retroviruses 1998, 14, 275–283.10.1089/aid.1998.14.275Search in Google Scholar

16. Martien R., Loretz B., Thaler M., Majzoob S., Bernkop-Schnürch A.: Chitosan – thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? J Biomed Mater Res A 2007, 82, 1–9.10.1002/jbm.a.31135Search in Google Scholar

17. Masotti A., Bordi F., Ortaggi G., Marino F., Palocci C.: A novel method to obtain chitosan/DNA nanospheres and a study of their release properties, Nanotechnology 2008, 19, doi: https://doi.org/10.1088/0957-4484/19/05/055302.10.1088/0957-4484/19/05/055302Open DOISearch in Google Scholar

18. Pachuk C.J., McCallus D.E., Weiner, D.B., Satishchandran C.: DNA vaccines challenges in delivery. Current Curr Opin Mol Ther 2000, 2, 188–198.Search in Google Scholar

19. Pearson L.D., Poss M.L., Demartini J.C.: Animal lentivirus vaccines: problems and prospects. Vet Immunol Immunopathol 1989, 20, 183–212.10.1016/0165-2427(89)90002-0Search in Google Scholar

20. Siegert W., Nitsche A.: Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313, 856–862.10.1016/j.bbrc.2003.11.177Search in Google Scholar

21. Sinha V., Singla A., Wadhawan S., Kaushik R., Kumria R., Bansal K., Dhawan S.: Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004, 274, 1–33.10.1016/j.ijpharm.2003.12.026Search in Google Scholar

22. Soeharsono S., Wilcox G.E., Dharma D.M.N., Hartaningsih N., Kertayadnya G., Budiantono A.: Species differences in the reaction of cattle to Jembrana disease virus infection. J Comp Pathol 1995, 112, 391–402.10.1016/S0021-9975(05)80020-9Search in Google Scholar

23. Wang G., Pan L., Zhang Y.: Approaches to improved targeting of DNA vaccines. Hum Vac Immunother 2011, 7, 1271–1281.10.4161/hv.7.12.1798322108038Search in Google Scholar

24. Wilcox G.E., Chadwick B.J., Kertayadnya G.: Recent advances in the understanding of Jembrana disease. Vet Microbiol 1995, 46, 249–255.10.1016/0378-1135(95)00089-SSearch in Google Scholar

25. Wilcox G.E., Soeharsono S., Dharma D.M.N., Copland J.W.: Jembrana disease and the bovine lentiviruses. Aciar Proc 1997, 75, 10–75.10.1111/j.1751-0813.1997.tb14379.x9258421Search in Google Scholar

26. Williams J.A.: Vector design for improved DNA vaccine efficacy, safety, and production. Vaccines 2013, 1, 225–249.10.3390/vaccines1030225449422526344110Search in Google Scholar

27. Winarti L., Martien R., Sismindari: Formulation of nanoparticles from short chain chitosan as gene delivery system and transfection against T47D cell line. Majalah Farmasi Indonesia 2011, 22, 204–211.Search in Google Scholar

28. Xu K., Ling Z.Y., Sun L., Xu Y., Bian C., He Y., Lu W., Chen Z., Sun B.: Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunol 2011, 24, 45–56.10.1089/vim.2010.0056303463821319978Search in Google Scholar

29. Ye Y., Xu Y., Liang W., Leung G.P.H., Cheung K., Zheng C., Chen F., Lam J.K.W.: Permeability across Calu-3 cells. J Drug Target 2013, 2330, 1–13.Search in Google Scholar

30. Zhou J., Wang L., Lu G., Zhou A., Zhu M., Li Q., Wang Z., Arken M., Wang A., He S.: Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite 2016, 23, 17.10.1051/parasite/2016017482487227055564Search in Google Scholar